Failure to Timely Report Suspected Narcotic Diversion and Abuse to State Agency
Summary
The deficiency involves the facility’s failure to timely report an allegation of abuse, specifically suspected narcotic diversion and medication tampering, to the State Agency within 2 hours as required by facility policy. During a shift-change narcotic count on the 300 medication cart, an agency RN questioned the appearance of one resident’s oxycodone 5 mg blister card, noting that cavity #59 was secured with regular medical tape and that the back of the blister pack appeared tampered with. Further inspection showed that while tablet #59 appeared consistent with oxycodone 5 mg, the remaining tablets in the card had different physical characteristics, and each blister cavity on the back had been covered with small pieces of paper tape. Upon removal and inspection, staff determined that all tablets except #59 had been replaced with a different medication that appeared consistent with loratadine. Following this discovery, nursing staff conducted a review and recount of all narcotic cards on the medication cart and identified additional oxycodone 5 mg and 10 mg blister cards that appeared to have been tampered with in a similar manner. A total of seven blister cards were ultimately identified as affected, with 279 narcotic tablets missing and replaced with other medications, including loratadine and over-the-counter pink Vitamin B-12 tablets. The affected residents had documented chronic pain and opioid orders: one resident with Parkinson’s disease, spinal fusion, and spondylosis had an oxycodone 5 mg PRN order; another resident with COPD, heart failure, renal failure, low back pain, and chronic pain had oxycodone 5 mg PRN for breakthrough pain; a hospice resident with emphysema, heart failure, renal failure, dementia, schizophrenia, PTSD, and spondylosis had oxycodone 5 mg PRN; another resident with stroke, emphysema, a left heel pressure ulcer, and pain had both scheduled and PRN oxycodone 5 mg; and a resident with paraplegia, renal failure, neurogenic bladder, anxiety, depression, bipolar disorder, and chronic pain syndrome had oxycodone 10 mg PRN for severe pain. At the time of surveyor observation in April, the affected residents generally reported their pain as controlled and denied unmanaged pain in the preceding months, and the blister cards then present in the cart did not appear tampered with. The facility’s internal documentation shows that the suspected diversion and tampering were reported to the DON by a staff RN at 6:21 a.m. on March 4, 2026, and the DON contacted the Administrator at 6:27 a.m. that same morning. However, the allegation was not successfully reported to the State Agency within 2 hours. A State Agency complaint intake print screen shows the reporting party as the Administrator, with awareness of the missing medication incident at 6:10 a.m. on March 4, 2026, and a submission date of 11:21 a.m. on March 5, 2026. The Administrator stated he attempted to report the incident on March 4 but did not complete the submission correctly due to user error and did not realize it had not been saved until he returned the next morning and resubmitted it. The facility’s Abuse, Neglect and Exploitation policy requires that all alleged violations involving abuse or resulting in serious bodily injury be reported to the Administrator, State Agency, Adult Protective Services, and other required agencies immediately, but not later than 2 hours after the allegation is made. The surveyors determined that the facility failed to meet this requirement when it did not report the suspected abuse (medication diversion and misappropriation) to the State Agency within the required 2-hour timeframe. The survey findings further detail the scope of the tampering identified in the facility’s medication diversion matrix. One resident’s oxycodone 5 mg card had 59 tablets missing or replaced; another resident had two oxycodone 5 mg cards with a total of 70 tablets missing or replaced; a hospice resident had one oxycodone 5 mg card with 11 tablets missing or replaced; another resident had one oxycodone 5 mg card with 55 tablets missing or replaced; and a resident with chronic pain syndrome had two oxycodone 10 mg cards with 84 tablets missing or replaced. The physical description of the tampering was consistent across cards, with paper tape precisely placed over each blister bubble and the original narcotic tablets replaced by non-narcotic medications. Despite the facility’s internal recognition of this as medication diversion and suspected abuse on the morning it was discovered, the external reporting to the State Agency was not completed within the 2-hour window specified by the facility’s own abuse, neglect, and exploitation policy, leading to the cited deficiency. Resident assessments and care plans documented that these residents were on scheduled and/or PRN opioid regimens for chronic pain and other serious conditions, and the MDS assessments showed varying levels of cognitive function, from no impairment to mild impairment. During the surveyor interviews in April, the residents involved generally denied uncontrolled or increased pain in the prior months and reported that their pain was well managed. Nonetheless, the deficiency centers on the facility’s failure to adhere to its mandated reporting procedures for alleged abuse, specifically the delayed reporting of suspected narcotic diversion and misappropriation of resident medications to the State Agency within the required 2-hour timeframe after the allegation was made.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



